The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cabot Oil & Gas Corporation (COG)

The Law Offices of Frank R. Cruz reminds investors of the upcoming October 13, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Cabot Oil & Gas Corporation (“Cabot Oil” or “the Company”) (NYSE: COG) securities between October 23, 2015 and June 12, 2020, inclusive (the “Class Period”).

If you are a shareholder who suffered a loss, click here to participate.

On July 26, 2019, the Company disclosed that it had received two proposed Consent Order and Agreements related to two Notices of Violation it had received from the Pennsylvania Department of Environmental Protection in 2017 for failure to prevent the migration of gas into fresh groundwater sources in the area surrounding Susquehanna County, Pennsylvania.

On this news, the Company’s share price fell $2.63, or over 12%, to close at $19.16 per share on July 26, 2019.

On June 15,

Read More

The Law Offices of Frank R. Cruz Announces Investigation of Fulton Financial Corporation (FULT) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Fulton Financial Corporation (“Fulton” or the “Company”) (NASDAQ: FULT) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On September 28, 2020, the U.S. Securities and Exchange Commission (“SEC”) announced that Fulton had been charged with accounting and disclosure violations. Specifically, the SEC stated that, in two quarters in which Fulton was on track to meet or beat analyst consensus EPS estimates, Fulton included a valuation allowance that “was at odds” with its reported methodology. Then, in mid-2017, “Fulton belatedly reversed the valuation allowance, increasing its EPS by a penny in a quarter when it otherwise would have fallen short of consensus estimates.”

On this news, the Company’s share price fell sharply during intraday trading on September 29, 2020.

Follow us for

Read More

The Law Offices of Frank R. Cruz Announces Investigation of Peabody Energy Corporation (BTU) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Peabody Energy Corporation (“Peabody” or the “Company”) (NYSE: BTU) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On September 28, 2018, Peabody announced that it did “not expect any production from North Goonyella in the fourth quarter of 2018” due to a fire occurring within the mine.

On this news, the Company’s stock price fell $5.54, or over 13%, to close at $35.64 per share on September 28, 2018, thereby injuring investors.

Then, on February 6, 2019, Peabody reported disappointing financial results for fourth quarter 2018 due to remediation costs and lack of production at the North Goonyella mine. The Company also announced that production would not resume at the mine until the “early months of 2020.”

On this news, the

Read More

Daxor Corporation to Exhibit and Showcase Compelling New Data at the Heart Failure Society of …

NEW YORK, Sept. 28, 2020 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces the Company will be exhibiting and showcasing new data at the Heart Failure Society of America’s (HFSA) Virtual Annual Scientific Meeting 2020 taking place from September 30th – October 6th, 2020.

The Company will host a booth and will be available online throughout the entire conference to discuss how Daxor’s BVA-100® blood test improves heart failure outcomes and answer questions. New data titled “ Red Cell Volume Phenotypes in Hospitalized Heart Failure Patients” (Poster #132) and “Cost-effectiveness Analysis of Early Blood Volume-Guided Management in Hospitalized Heart Failure Patients” ( Poster #331) will be highlighted in the Poster Hall accompanied by a narrative from the principal investigators.

“The HFSA Annual Scientific Meeting is an exciting venue to increase awareness and utilization

Read More